Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary Fricker

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|December 24, 2021
Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception PointsDaniela Goyes, John Paul Nsubuga, Esli Medina-Morales, et al.
JAMA Network Open|November 2, 2023
Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy ChangeBehnam Saberi, Ahmet Gurakar, Hani Tamim, et al.
Gastroenterology Research|July 16, 2021
Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19Hirsh D Trivedi, Robert Wilechansky, Daniela Goyes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 11, 2024
Waitlist and transplant outcomes in patients with metabolic dysfunction-associated steatotic liver disease and autoimmune hepatitisEsli Medina-Morales, Mohamed Ismail, Ritik M Goyal, et al.
Digestive Diseases and Sciences|September 10, 2017
Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatmentJustin Chan, Neliswa Gogela, Hui Zheng, et al.
Journal of Clinical and Translational Hepatology|October 28, 2022
Regional and National Trends of Adult Living Donor Liver Transplantation in the United States Over the Last Two DecadesSaleh A Alqahtani, Ahmet Gurakar, Hani Tamim, et al.
Hepatology (Baltimore, Md.)|September 17, 2020
Risk Prediction Models for Post-Operative Mortality in Patients With CirrhosisNadim Mahmud, Zachary Fricker, Rebecca A Hubbard, et al.
Contemporary Clinical Trials Communications|November 13, 2023
INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusionEthan Weinberg, Suditi Rahematpura, Stevan A Gonzalez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 21, 2024
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant populationK Rajender Reddy, Ethan M Weinberg, Stevan A Gonzalez, et al.
Hepatology (Baltimore, Md.)|October 18, 2021
Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitisKunpeng Hu, Maria C Perez-Matos, Josepmaria Argemi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|December 24, 2021
Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception PointsDaniela Goyes, John Paul Nsubuga, Esli Medina-Morales, et al.
JAMA Network Open|November 2, 2023
Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy ChangeBehnam Saberi, Ahmet Gurakar, Hani Tamim, et al.
Gastroenterology Research|July 16, 2021
Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19Hirsh D Trivedi, Robert Wilechansky, Daniela Goyes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 11, 2024
Waitlist and transplant outcomes in patients with metabolic dysfunction-associated steatotic liver disease and autoimmune hepatitisEsli Medina-Morales, Mohamed Ismail, Ritik M Goyal, et al.
Digestive Diseases and Sciences|September 10, 2017
Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatmentJustin Chan, Neliswa Gogela, Hui Zheng, et al.
Journal of Clinical and Translational Hepatology|October 28, 2022
Regional and National Trends of Adult Living Donor Liver Transplantation in the United States Over the Last Two DecadesSaleh A Alqahtani, Ahmet Gurakar, Hani Tamim, et al.
Hepatology (Baltimore, Md.)|September 17, 2020
Risk Prediction Models for Post-Operative Mortality in Patients With CirrhosisNadim Mahmud, Zachary Fricker, Rebecca A Hubbard, et al.
Contemporary Clinical Trials Communications|November 13, 2023
INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusionEthan Weinberg, Suditi Rahematpura, Stevan A Gonzalez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 21, 2024
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant populationK Rajender Reddy, Ethan M Weinberg, Stevan A Gonzalez, et al.
Hepatology (Baltimore, Md.)|October 18, 2021
Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitisKunpeng Hu, Maria C Perez-Matos, Josepmaria Argemi, et al.
Pageof 3